← FDA DRUG APPROVALS

FDA ANDA · ANDA074265

ATENOLOL

Sponsor: CHARTWELL RX

APPLICATION
ANDA074265
TYPE
ANDA
ORIGINAL APPROVAL
1994-02-28
LATEST ACTION
2000-01-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATENOLOLDiscontinued
ATENOLOL 100MG · TABLET · ORAL
ATENOLOLDiscontinued
ATENOLOL 25MG · TABLET · ORAL
ATENOLOLDiscontinued
ATENOLOL 50MG · TABLET · ORAL

Approval history

2000-01-27Manufacturing (CMC) · Supplement 14AP
2000-01-27Manufacturing (CMC) · Supplement 12AP
2000-01-27Manufacturing (CMC) · Supplement 15AP
2000-01-27Manufacturing (CMC) · Supplement 13AP
1997-10-21Manufacturing (CMC) · Supplement 10AP
1997-08-08Labeling · Supplement 11AP
1997-06-04Manufacturing (CMC) · Supplement 8AP
1997-04-01Labeling · Supplement 9AP
1996-03-13Manufacturing (CMC) · Supplement 7AP
1996-03-13Labeling · Supplement 5AP
1996-03-13Manufacturing (CMC) · Supplement 3AP
1996-03-13Manufacturing (CMC) · Supplement 6AP
1996-03-13Manufacturing (CMC) · Supplement 4AP
1994-09-02Labeling · Supplement 2AP
1994-08-01Labeling · Supplement 1AP
1994-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →